A comparison of anatomic and cellular transcriptome structures across 40 human brain diseases
暂无分享,去创建一个
Trygve E Bakken | M. Hawrylycz | E. Lein | A. Evans | A. Jegga | T. Nickl-Jockschat | J. Schulkin | Y. Zeighami | Jeremy A. Miller | Z. Peterson
[1] Michael F. Green,et al. Mapping genomic loci implicates genes and synaptic biology in schizophrenia , 2022, Nature.
[2] M. Olive,et al. Drugs of Abuse Differentially Alter the Neuronal Excitability of Prefrontal Layer V Pyramidal Cell Subtypes , 2021, Frontiers in Cellular Neuroscience.
[3] J. Concato,et al. Bi-Ancestral Depression GWAS in the Million Veteran Program and Meta-Analysis in >1.2 Million Subjects Highlights New Therapeutic Directions , 2021, Nature Neuroscience.
[4] J. Mandel,et al. The concurrence of multiple sclerosis and glioblastoma. , 2021, Multiple sclerosis and related disorders.
[5] Ryan J H West,et al. Lessons learned from CHMP2B, implications for frontotemporal dementia and amyotrophic lateral sclerosis , 2020, Neurobiology of Disease.
[6] Saskia E. J. de Vries,et al. VIP interneurons in mouse primary visual cortex selectively enhance responses to weak but specific stimuli , 2020, eLife.
[7] P. Kharchenko,et al. Identification of epilepsy-associated neuronal subtypes and gene expression underlying epileptogenesis , 2020, Nature Communications.
[8] D. Goldstein,et al. Expansion of the GRIA2 phenotypic representation: a novel de novo loss of function mutation in a case with childhood onset schizophrenia , 2020, Journal of Human Genetics.
[9] Howard Y. Chang,et al. The road ahead in genetics and genomics , 2020, Nature Reviews Genetics.
[10] D. Geschwind,et al. Transcriptomic and cellular decoding of regional brain vulnerability to neurogenetic disorders , 2020, Nature Communications.
[11] S. Liebscher,et al. Exciting Complexity: The Role of Motor Circuit Elements in ALS Pathophysiology , 2020, Frontiers in Neuroscience.
[12] S. Carmichael,et al. Glia in neurodegeneration: Drivers of disease or along for the ride? , 2020, Neurobiology of Disease.
[13] G. Trynka,et al. From GWAS to Function: Using Functional Genomics to Identify the Mechanisms Underlying Complex Diseases , 2020, Frontiers in Genetics.
[14] Kyle J. Gaulton,et al. An atlas of gene regulatory elements in adult mouse cerebrum , 2020, Nature.
[15] Monika S. Kowalczyk,et al. Systematic comparison of single-cell and single-nucleus RNA-sequencing methods , 2020, Nature Biotechnology.
[16] Hongkui Zeng,et al. A taxonomy of transcriptomic cell types across the isocortex and hippocampal formation , 2020, Cell.
[17] E. Westman,et al. Longitudinal degeneration of the basal forebrain predicts subsequent dementia in Parkinson's disease , 2020, Neurobiology of Disease.
[18] Christina F. Chick,et al. Identification of Common Neural Circuit Disruptions in Emotional Processing Across Psychiatric Disorders. , 2020, The American journal of psychiatry.
[19] Yuedong Yang,et al. Identifying Common Genes, Cell Types and Brain Regions Between Diseases of the Nervous System , 2019, Front. Genet..
[20] F. Sanz,et al. The DisGeNET knowledge platform for disease genomics: 2019 update , 2019, Nucleic Acids Res..
[21] Matthew Hur,et al. Dopamine Deficiency Reduces Striatal Cholinergic Interneuron Function in Models of Parkinson’s Disease , 2019, Neuron.
[22] Allan R. Jones,et al. Conserved cell types with divergent features in human versus mouse cortex , 2019, Nature.
[23] Jie Li,et al. Application of Computational Biology to Decode Brain Transcriptomes , 2019, Genom. Proteom. Bioinform..
[24] Ethan M. Goldberg,et al. Vasoactive intestinal peptide-expressing interneurons are impaired in a mouse model of Dravet syndrome , 2019, eLife.
[25] Sojib Bin Zaman,et al. Global, regional, and national burden of neurological disorders, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. , 2017, The Lancet. Neurology.
[26] William M Carroll,et al. The global burden of neurological disorders , 2019, The Lancet Neurology.
[27] Ellis Patrick,et al. Deconvolving the contributions of cell-type heterogeneity on cortical gene expression , 2019, bioRxiv.
[28] Alexandra K. Gold,et al. Treating Circadian Rhythm Disruption in Bipolar Disorder , 2019, Current Psychiatry Reports.
[29] R. Moyeed,et al. Gene expression meta-analysis of Parkinson’s disease and its relationship with Alzheimer’s disease , 2019, Molecular Brain.
[30] V. Vacic,et al. Genome-wide analysis of insomnia in 1,331,010 individuals identifies new risk loci and functional pathways , 2019, Nature Genetics.
[31] Stephan J Sanders,et al. Integrative functional genomic analysis of human brain development and neuropsychiatric risks , 2018, Science.
[32] Herng‐Ching Lin,et al. Association of migraines with brain tumors: a nationwide population-based study , 2018, The Journal of Headache and Pain.
[33] Charles E. Dean,et al. Neural circuitry and precision medicines for mental disorders: are they compatible? , 2018, Psychological Medicine.
[34] Gregory J. Hunt,et al. Dtangle: Accurate and Robust Cell Type Deconvolution , 2018, Bioinform..
[35] Manoj Kumar,et al. Linking spatial gene expression patterns to sex-specific brain structural changes on a mouse model of 16p11.2 hemideletion , 2018, Translational Psychiatry.
[36] D. Vieau,et al. Hypothalamic Alterations in Neurodegenerative Diseases and Their Relation to Abnormal Energy Metabolism , 2018, Front. Mol. Neurosci..
[37] H. van Bokhoven,et al. Inhibitory control of the excitatory/inhibitory balance in psychiatric disorders , 2018, F1000Research.
[38] Allan R. Jones,et al. Shared and distinct transcriptomic cell types across neocortical areas , 2017, bioRxiv.
[39] D. Tropea,et al. Editorial: Biology of Brain Disorders , 2017, Front. Cell. Neurosci..
[40] Núria Queralt-Rosinach,et al. DisGeNET: a comprehensive platform integrating information on human disease-associated genes and variants , 2016, Nucleic Acids Res..
[41] Grace X. Y. Zheng,et al. Massively parallel digital transcriptional profiling of single cells , 2016, Nature Communications.
[42] Brittany N. Lasseigne,et al. Post-mortem molecular profiling of three psychiatric disorders , 2016, bioRxiv.
[43] A. Singleton,et al. Genetic and phenotypic characterization of complex hereditary spastic paraplegia , 2016, Brain : a journal of neurology.
[44] Seth G. N. Grant,et al. Identification of Vulnerable Cell Types in Major Brain Disorders Using Single Cell Transcriptomes and Expression Weighted Cell Type Enrichment , 2016, Front. Neurosci..
[45] Núria Queralt-Rosinach,et al. DisGeNET-RDF: harnessing the innovative power of the Semantic Web to explore the genetic basis of diseases , 2015, bioRxiv.
[46] Allan R. Jones,et al. Canonical Genetic Signatures of the Adult Human Brain , 2015, Nature Neuroscience.
[47] Xiang Zhang,et al. Comparative analysis of a novel disease phenotype network based on clinical manifestations , 2015, J. Biomed. Informatics.
[48] Jes Olesen,et al. The Cost of Brain Diseases: A Burden or a Challenge? , 2014, Neuron.
[49] Zhicheng Lin,et al. SLC6A3 is a risk factor for Parkinson's disease: A meta-analysis of sixteen years’ studies , 2014, Neuroscience Letters.
[50] Allan R. Jones,et al. Transcriptional Landscape of the Prenatal Human Brain , 2014, Nature.
[51] Ta-Liang Chen,et al. Psychiatric Disorders after Epilepsy Diagnosis: A Population-Based Retrospective Cohort Study , 2013, PloS one.
[52] Allan R. Jones,et al. An anatomically comprehensive atlas of the adult human brain transcriptome , 2012, Nature.
[53] Joanna M Biernacka,et al. Genetic variability in the NMDA‐dependent AMPA trafficking cascade is associated with alcohol dependence , 2012, Addiction biology.
[54] Karen Santucci,et al. Psychiatric disease and drug abuse , 2012, Current opinion in pediatrics.
[55] A. Serretti,et al. Case–control association study of GRIA1, GRIA2 and GRIA4 polymorphisms in bipolar disorder , 2012, International journal of psychiatry in clinical practice.
[56] S. de Ribaupierre,et al. Language Mapping in Temporal Lobe Epilepsy in Children: Special Considerations , 2012, Epilepsy research and treatment.
[57] Etienne Sibille,et al. Between destiny and disease: Genetics and molecular pathways of human central nervous system aging , 2011, Progress in Neurobiology.
[58] Huan Cai,et al. Therapeutic potential of vasoactive intestinal peptide and its receptors in neurological disorders. , 2010, CNS & neurological disorders drug targets.
[59] J. Cadet,et al. Polysomnogram changes in marijuana users who report sleep disturbances during prior abstinence. , 2010, Sleep medicine.
[60] R. Bell,et al. Concurrence of High-Grade Brainstem Glioma and Multiple Sclerosis , 2010, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.
[61] P. Kaplan. Epilepsy and obsessive-compulsive disorder , 2010, Dialogues in clinical neuroscience.
[62] M. Owen,et al. Genetic overlap between autism, schizophrenia and bipolar disorder , 2009, Genome Medicine.
[63] Jing Chen,et al. ToppGene Suite for gene list enrichment analysis and candidate gene prioritization , 2009, Nucleic Acids Res..
[64] K. Wilhelmsen,et al. The role of aldehyde dehydrogenase-1 (ALDH1A1) polymorphisms in harmful alcohol consumption in a Finnish population , 2008, Human Genomics.
[65] A. Granholm,et al. Mood, memory and movement: an age-related neurodegenerative complex? , 2008, Current aging science.
[66] Karen I Bolla,et al. Sleep disturbance in heavy marijuana users. , 2008, Sleep.
[67] Peter Boesiger,et al. Abnormal activity in hypothalamus and amygdala during humour processing in human narcolepsy with cataplexy. , 2008, Brain : a journal of neurology.
[68] M. Ashburner,et al. The OBO Foundry: coordinated evolution of ontologies to support biomedical data integration , 2007, Nature Biotechnology.
[69] Q. Li,et al. Concurrence of glioma and multiple sclerosis , 2005, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.
[70] Doron Lancet,et al. Genome-wide midrange transcription profiles reveal expression level relationships in human tissue specification , 2005, Bioinform..
[71] David W. Miller,et al. Glial cell inclusions and the pathogenesis of neurodegenerative diseases. , 2004, Neuron glia biology.
[72] N. Schork,et al. Identifying genes and genetic variation underlying human diseases and complex phenotypes via recombination mapping , 2004, The Journal of physiology.
[73] P. Shannon,et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. , 2003, Genome research.
[74] J. Olesen,et al. The burden of brain diseases in Europe , 2003, European journal of neurology.
[75] R. Ptak,et al. Hypothalamic amnesia with spontaneous confabulations: A clinicopathologic study , 2001, Neurology.
[76] G. Halliday,et al. Loss of thalamic intralaminar nuclei in progressive supranuclear palsy and Parkinson's disease: clinical and therapeutic implications. , 2000, Brain : a journal of neurology.
[77] D. Borchelt,et al. Amyotrophic lateral sclerosis and Alzheimer disease. Lessons from model systems. , 1997, Revue neurologique.
[78] I. Gozes,et al. Neuroprotective strategy for Alzheimer disease: intranasal administration of a fatty neuropeptide. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[79] S. Currie,et al. Concurrence of multiple sclerosis and glioma , 1974, Journal of neurology, neurosurgery, and psychiatry.
[80] R. Reilmann. Parkinsonism in Huntington's disease. , 2019, International review of neurobiology.
[81] Martin J. Schmidt,et al. Neurodevelopment, GABA System Dysfunction, and Schizophrenia , 2015, Neuropsychopharmacology.
[82] W. Mason. THE CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES , 2014 .